Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   ADCOCK INGRAM
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
ADCOCK INGRAM
Jun-14
ALKEM LABORATORIES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs3,625319-   
Low Rs2,835230-   
Sales per share (Unadj.) Rs970.194.9-  
Earnings per share (Unadj.) Rs84.2-23.9-  
Cash flow per share (Unadj.) Rs110.2-19.8-  
Dividends per share (Unadj.) Rs50.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs756.474.5-  
Shares outstanding (eoy) m119.57168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.32.9 115.1%   
Avg P/E ratio x38.4-11.5 -334.1%  
P/CF ratio (eoy) x29.3-13.9 -211.6%  
Price / Book Value ratio x4.33.7 115.8%  
Dividend payout %59.40-   
Avg Mkt Cap Rs m386,20746,340 833.4%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m21,3142,908 732.8%   
Avg. sales/employee Rs Th03,730.7-  
Avg. wages/employee Rs Th0677.5-  
Avg. net profit/employee Rs Th0-940.1-  
INCOME DATA
Net Sales Rs m115,99316,016 724.2%  
Other income Rs m2,161112 1,926.6%   
Total revenues Rs m118,15316,128 732.6%   
Gross profit Rs m15,065-2,775 -542.8%  
Depreciation Rs m3,104691 449.1%   
Interest Rs m1,074434 247.5%   
Profit before tax Rs m13,048-3,788 -344.4%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,980237 1,258.7%   
Profit after tax Rs m10,068-4,036 -249.5%  
Gross profit margin %13.0-17.3 -74.9%  
Effective tax rate %22.8-6.2 -365.5%   
Net profit margin %8.7-25.2 -34.4%  
BALANCE SHEET DATA
Current assets Rs m86,06411,730 733.7%   
Current liabilities Rs m37,0716,600 561.7%   
Net working cap to sales %42.232.0 131.9%  
Current ratio x2.31.8 130.6%  
Inventory Days Days33111 29.4%  
Debtors Days Days67124 54.1%  
Net fixed assets Rs m37,2456,838 544.7%   
Share capital Rs m23974 321.5%   
"Free" reserves Rs m90,2080-   
Net worth Rs m90,44712,571 719.5%   
Long term debt Rs m04,418 0.0%   
Total assets Rs m124,54123,747 524.4%  
Interest coverage x13.2-7.7 -170.1%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 138.1%   
Return on assets %8.9-15.2 -59.0%  
Return on equity %11.1-32.1 -34.7%  
Return on capital %15.6-19.8 -78.8%  
Exports to sales %14.60-   
Imports to sales %00-   
Net fx Rs m12,7270-   
CASH FLOW
From Operations Rs m16,8251,367 1,230.7%  
From Investments Rs m1,128-420 -268.8%  
From Financial Activity Rs m-17,6084,009 -439.2%  
Net Cashflow Rs m4164,957 8.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.4 Rs / ZAR

Compare ALKEM LABORATORIES With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: SUVEN LIFE SCIENCES  PIRAMAL PHARMA  BIOCON   ISHITA DRUGS  VEERHEALTH CARE  



Today's Market

Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.